Implantable living materials deliver drugs on demand

living materials – Engineered bacteria sealed in a jelly-like hydrogel can reduce infection in mice, pointing to implantable, on-demand therapeutics.

A future therapy may not need to wait for symptoms to appear. Researchers are testing an implantable “living material” that can sense infection and respond from inside the body, potentially shifting treatment away from pills and shots and toward an automatic, at-the-source defense.

In a study published in Science. the team described successfully implanting a mouse with a therapeutic made from genetically engineered bacteria enclosed in a jelly-like container.. The approach is designed to be activated when pathogens are present. offering a route to treatments that could be deployed for infection prevention during surgeries or serve as a longer-term therapy that reacts to threats on its own.

The idea builds on work showing that bacteria can be engineered to recognize pathogens and then self-destruct. releasing drugs aimed at killing the invader.. That “living” mechanism is not entirely new. but the researchers say the key challenge has been controlling where the microbes go after implantation.

A major concern. highlighted by the study’s lead author. Tetsuhiro Harimoto. is the safety risk of introducing live bacteria into the body.. If engineered microbes were able to escape and spread, they could potentially cause infections instead of preventing them.. Solving that containment problem is what the hydrogel is meant to address.

To keep the bacteria from leaking out. the researchers designed a hydrogel—described as a permeable. mesh-like material that is also stiff enough to hold a live. growing bacterial population in place.. The capsule-like matrix was compared to tapioca pearls from boba tea. but with increased stiffness so the container can resist typical stresses inside the body.

Before moving to animal testing. the hydrogel underwent a series of stress tests intended to mimic conditions that could weaken a device over time.. The team carried out a “fatigue” test that involved stretching the capsule 10,000 times to determine whether it would break.. They also kept the hydrogel in a nutrient broth for six months. then repeatedly checked whether bacteria had escaped into the surrounding liquid.

In that long-duration containment check, the researchers periodically sampled the broth every week or two to see whether any bacteria came out. Eventually, they concluded the system was behaving as intended—holding the engineered microbes inside the hydrogel over the testing window.

For the final test. the researchers implanted the hydrogel into mice using a surgery approach they likened to placing a prosthetic pin to support healing bone.. Some mice received a prosthetic pin treated with the living hydrogel containing engineered bacteria that could detect a specific pathogen. Pseudomonas aeruginosa.. Other mice received pins without the therapeutic material.

To simulate an infection, the researchers introduced P.. aeruginosa to the surgery site.. The implanted mice treated with the engineered living materials showed a harder time for the pathogen to replicate. with results described as a clear difference between animals treated with the living hydrogel and those treated without therapeutics.

The findings suggest hydrogels could contain engineered. infection-fighting bacteria for months at a time without leaking. which an outside expert called a first.. Quanyin Hu. an associate professor in pharmacy at the University of Wisconsin–Madison who wrote a related commentary in Science and was not involved in the work. emphasized that the central advance is successful containment at the implantation site.

Hu also pointed to broader possibilities for the same platform.. In theory. the strategy could be adapted for other medical challenges. including preventing tumors from coming back. treating inflammation. or administering other kinds of drugs—so long as the engineered response can be matched to the biological signals involved.

The researchers say their work is already moving toward additional applications. Harimoto plans to start a lab at Cornell University in August, where he intends to test other uses for programmable living materials, including potential applications for cancer.

The broader appeal of the concept is that it turns therapy into a reactive system.. Rather than waiting for diagnosis and then delivering a drug. the approach aims to keep a controlled biological “factory” in place that can respond when pathogens are present—an engineering challenge as much as it is a biomedical one. centered on balancing containment. durability. and biological activity.

For now, the results are in mice, and the next step will be validation in humans. If safety and performance hold up, implantable living materials could offer a new class of therapies that combine programmable sensing with controlled, localized drug delivery.

implantable living materials engineered bacteria hydrogel drug delivery infection treatment Pseudomonas aeruginosa responsive therapeutics